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Abstract
Patients with heart disease among mid-life and old age are at a
higher risk for mental illness like depression, anxiety or
schizophrenia. In this research, we investigate the role of
cardiovascular disease as a risk factor for mental illness. Long
term use of antibiotics, along with gender, age, BMI,
hypertension and the usage of drugs like clarithromycin, Z-pak,
and supplements such as folate, vitamin B6 are all a risk factors
for predicting mental illness.

Objective
This research focuses on identifying the mental illnesses for
patients with heart disease using machine learning
The research also focuses on identifying the effects of
drug/supplement usage as a risk factor on mental illnesses

Background
Coronary Heart Disease (CHD) and mental illness are one of
the major reasons of mortality and morbidity among general
population
Person with Cardiovascular Disease (CVD) has more
depression than general population [1]
On the other hand, person with more depression are likely to
develop CVD and has higher mortality than general
population [2]
Research show that mood and anxiety disorders are one of
the major symptoms of causing cardiovascular disease [3,4]
The goal of the following research is to predict Depression,
Anxiety and Schizophrenia using this dataset

Dataset
 Dataset was obtained from United Health Services.
The Dataset contains 68647 rows and 29 attributes
67% of the patients has no disease
33% of the patients has one or more mental health disease
Attributes of dataset are as follows:
 Gender, age, InsulinDependentDiabetes, Hypertension,
Osteoarthritis, CancerMalignant, Obesity, Depression, Anxiety,
Schizophrenia, CongenitalDiseaseOfHeart, HeartFailure,
CerebrovascularDisease, Atherosclerosis, CoronaryArteryDisease,
NutritionDeficiency, ElevatedCRP, ElevatedESR,
LongTermUseOfAntibiotics, BMI, LAB, LabValue, E_Mycin,
Clarithromycin, Z_Pak, Folate, VitB6, CoQ, Omega3FishOil

Disease is a computed column
If depression is yes, or anxiety is yes, or schizophrenia is
yes, or all the mental illnesses are a yes then Disease = Yes
 Class imbalance
 15% depression cases
 22% anxiety cases
 0.38% schizophrenia cases
Patients with more than one illness is very less (≈ 0.30%)
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Method

Results

97% of LAB and LabValue are missing data – removed from the
analysis
Compute Disease for each row
70% of the dataset is used for 5-fold CV for training the model
and 30% of the dataset is used for testing the prediction model
Methods applied:
 Method 1: Whole dataset is processed without sampling
 Method 2: One-hot encoded targets without sampling
 Method 3: Under sampled dataset
 Under sampling: The total sample size of non-mental
illness cases are matched to number of total mental illness
case
 Method 4: Under sampled dataset split to Male/Female
 Method 5: Deep learning method with 1 hidden layer (16
neurons)
Classification Algorithms:
 Random Forest
 Decision Tree Classifier
 XGBoost (Extreme Gradient Boosting)
 LightGBM
 Deep Learning
 Deep learning method with 1 hidden layer (16 neurons)
 1 Input layer (24 nodes), 1 Hidden Layer(16 nodes),
Dropout layer to prevent
 overfitting (Early stopping criterion), 1 output layer

Metrics Used
Accuracy (Goal)
 Ratio of correctly classified illness/non-illness cases to
total rows in the dataset
 Higher Accuracy = Better Performance
 Precision
 How many of the non-mental illness case labeled are
actual non-illness?
 Recall/Sensitivity
 How many non-mental illness cases were predicted to be
non-illness
F1 Score
 Average of precision and recall
Specificity (Goal)
 Off all mental illness cases, how many did we correctly
predict as mental illness
AUROC (Area Under the Receiver Operating Curve)
(Goal)
 Tells us how well can the model differentiate between
mental and non-mental illness cases
 The higher the score, the model can predict and
approximate well on new samples

Figure 2: Performance comparison for Depression

Figure 4: Performance comparison for Schizophrenia

Figure 3: Performance comparison for Anxiety

Figure 5: Performance comparison for Disease

Best model with high accuracy, specificity and AUROC is
selected
Models that perform poorly in any of these measures are
removed from best performing model
Deep learning model showed high accuracy, specificity and
AUROC – best performing model for Depression, Anxiety
and Disease
XGB’s performance is better for Schizophrenia

Variable Selection

Using logistic regression, statistically significant (p<0.05)
variables are selected and trained using deep learning (Fig 6-9)
18 variables of 26 predictors are enough to predict Anxiety and
Disease
Highlighted represent common features in all the mental illnesses
Variables for Depression
Variables for Schizophrenia
 age
 Gender
 Hypertension
 age
 Osteoarthritis
 Hypertension
 CancerMalignant
 Osteoarthritis
 HeartFailure
 Obesity
 CoronaryArteryDisease
 HeartFailure
 ElevatedCRP
 CoronaryArteryDisease
 LongTermUseOfAntibiotics
 BMI
 Clarithromycin
 Z_Pak
 Z_Pak
 Folate
 VitB6



















Variables for Anxiety
Gender
age
InsulinDependentDiabetes
Hypertension
Osteoarthritis
CancerMalignant
Obesity
CongenitalDiseaseOfHeart
HeartFailure
Atherosclerosis
CoronaryArteryDisease
LongTermUseOfAntibiotics
BMI
E_Mycin
Clarithromycin
Z_Pak
Folate
VitB6




















Variables for Disease
Gender
age
InsulinDependentDiabetes
Hypertension
Osteoarthritis
CancerMalignant
Obesity
CongenitalDiseaseOfHeart
HeartFailure
Atherosclerosis
CoronaryArteryDisease
LongTermUseOfAntibiotics
BMI
E_Mycin
Clarithromycin
Z_Pak
Folate
VitB6

These variables may increase or decrease the mental illnesses that
are yet to be investigated

Conclusion

Figure 6: Performance comparison after variable
selection for Depression

Risk Factors for mental illness: Long term use of antibiotics,
along with gender, age, BMI, hypertension and the usage of
drugs like clarithromycin, Z-pak, folate, vitamin B6
Using the selected features from the previous section, the
below mentioned accuracy, specificity and AUROC was
achieved for each mental illness
Depression has 74% accuracy, 67% specificity and 83%
AUROC using deep learning
Anxiety has 80% accuracy, specificity and AUROC using
logistic regression + deep learning
Schizophrenia has 63% accuracy, 70% specificity and 63%
AUROC using XGB
Disease has 84% accuracy, 73% specificity and 84% AUROC
using logistic regression + deep learning

Figure 7: Performance comparison after variable
selection for Anxiety
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